This invention relates to novel substituted purinyl-pyrazol derivatives (I) and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels.
本发明涉及新型取代
嘌呤基-
吡唑衍
生物(I)及其用作
钾通道调节剂的用途。此外,本发明还涉及制备用于治疗或缓解与
钾通道活性相关的疾病或障碍的药物组合物。